Abstract
Introduction: Parkinson's disease is one of the most prevalent neurodegenerative diseases worldwide. It's clinical presentation, motor and non-motor signs have been described previously. In our population, we don't know the frequency of those signs and symptoms.
Objective: Describe the clinical presentation, motor and non-motor signs of a cohort of patients with Parkinson's disease, that were evaluated in a movement disorders center of reference, at Bogotá, Colombia.
Materials and methods: Descriptive retrospective study of patients with Parkinson's disease, who went to the movement disorders clinic between January 2013 and June 2015. Patients were organized depending on the time from the onset of the disease. Socio-demographic variables, motor and non-motor signs and symptoms where studied. Frequencies, mean and proportions were analyzed using SPSS 22 version.
Results: 446 patients were analyzed, from which 50.7% were women. The mean age found was 68 years old. We found hiposmia in 33.6% of patients and abnormalities in REM sleep in 32% of them. The first motor symptoms noticed by the patient were tremor (62.3%), bradykinesia (15.9%), stiffness (12.6%), difficulty walking (8.1%), balance problems (1.6%) and falls (1.6%).
Conclusion: Parkinson's disease is the second most frequent neurodegenerative disease worldwide. Its clinical presentation is diverse, and in our population we have never study the patterns of presentation. We found similar frequencies compared with the international registries of this disease, with some difference in demographic and non-motor symptoms.
References
Cohen RM. Epidemiology and Clinical Diagnosis: Alzheimer Disease. PET Clin [Internet]. 2013 Oct [cited 2015 Jul 11];8(4):391-405. Available from: http://www.sciencedirect.com/science/article/pii/S1556859813000631.
Chen S-Y, Tsai S-T. The Epidemiology of Parkinson's Disease. Tzu Chi MedJ [Internet]. 2010 Jun [cited 2015 Jul 11];22(2):73-81. Available from: http://wwwsciencedirect.com/science/article/pii/S1016319010600444.
De Lau LML, Breteler MMB. Epidemiology of Parkinson's disease. Lancet Neurol [Internet]. 2006 Jun [cited 2014 Oct3];5(6):525-35. Available from: http://wwwsciencedirect.com/science/article/pii/S1474442206704719.
Van Den Eeden SK. Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity. Am J Epidemiol [Internet]. 2003 Jun 1 [cited 2015 Apr 3];157(11):1015-22. Available from: http://aje.oxfordjournals.org/cgi/content/long/157/11/1015
Pradilla A. G, Vesga A. BE, León-Sarmiento FE. Estudio neuro-epidemiológico nacional (EPINEURO) colombiano. Rev Panam Salud Pública [Internet]. Organización Panamericana de la Salud; 2003 Aug [cited 2015 Jul 11];14(2):104-11. Available from: http://wwwscielosp.org/scielo.php?script-sci_arttext&pid-S1020-49892003000700005&lng=en&nrm=iso&tlng=es.
Sánchez JL, Buriticá O, Pineda D, Uribe CS, Palacio LG. Prevalence of Parkinson's disease and parkinsonism in a Colombian population using the capture-recapture method. Int J Neurosci [Internet]. Informa UK Ltd UK; 2004 Feb 7 [cited 2015 Jul 11];114(2):175-82. Available from: http://informahealthcarecom/doi/abs/10.1080/00207450490269444#.VaGJhd6Zz9o.mendeley.
Burbulla LF, Krüger R. Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease. J Neurol Sci. 2011;306(1-2):1-8.
Johnson KE. Approach to the Patient with Parkinson Disease. Prim Care Clin Off Pract [Internet]. Elsevier; 2015 Jul 11;42(2):205-15. Available from: http://dx.doi.org/10.1016/j.pop.2015.01.005.
Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181-4.
Sung VW, Nicholas AP. Nonmotor symptoms in Parkinson's disease: expanding the view of Parkinson's disease beyond a pure motor, pure dopaminergic problem. Neurol Clin [Internet]. 2013 Aug [cited 2015 Jun 13];31(3 Suppl):S1-16. Available from: http://www.sciencedirect.com/science/article/pii/S0733861913000522.
Armstrong MJ, Gruber-Baldini AL, Reich SG, Fishman PS, Lachner C, Shulman LM. Which features of Parkinson's disease predict earlier exit from the workforce? Parkinsonism Relat Disord [Internet]. Elsevier; 2015 Jul 11;20(11):1257-9. Available from: http://dx.doi.org/10.1016/j.parkreldis.2014.08.005
Jankovic J., McDermott M., Carter J., et al: Variable expression of Parkinsons disease: A base-line analysis of the DATATOP cohort. Neurology. 1990; 40(10):1529-34.
Cervantes-Arriaga A, Rodríguez-Violante M, López-Ruiz M, Estrada-Bellmann I, Zuñiga-Ramírez C, Otero-Cerdeira E, et al. Profile characterization of Parkinsons disease in Mexico: ReMePARK study. Gac Med Mex. 2013;149(5):497-501.
Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, et al; PRIAMO study group. The Priamo Study: A Multicenter Assessment of Nonmotor Symptoms and Their Impact on Quality of Life in Parkinson's Disease. Mov Disord.2009;24(11):1641-9.
Foltynie T, Brayne C, Barker RA. The heterogeneity of idiopathic Parkinson's disease. J Neurol. 2002;249(2):138-45.
van Rooden SM, Colas F, Martínez-Martín P, Visser M, Verbaan D, Marinus J, et al. Clinical subtypes of Parkinson's disease. Mov Disord. 2011;26(1):51-8.
Diazgranados JA, Chan L, Gomez LF, Lozano AF, Ramirez M. Descripción de la población de pacientes con enfermedad de Parkinson en un centro médico neurológico en la ciudad de Cali, Colombia. Acta Neurol Colomb. 2011;27(4):205-10.
Martínez-Martín P, Hernández B, Ricart J; FAST Study Group. Factors determining when to start levodopa/carbidopa/enta-capone treatment in Spanish patients with Parkinson's disease. Neurología. 2014;29(3):153-60.
Cervantes-Arriaga A, Rodríguez-Violante M, Camacho-Ordóñez A, González-Latapi P, López-Ruiz M, Estrada-Bellmann I, et al. Time from motor symptoms onset to diagnosis of Parkinsons disease in Mexico. Gac Med Mex. 2014;150(2):242-7.
Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters ECh, Berendse HW Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol. 2004;56(2):173-81.
Martinez-Martin P, Schapira AH, Stocchi F, et al. Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 2007;22(11):1623-9.
Truong DD1, Bhidayasiri R, Wolters E. Management of nonmotor symptoms in advanced Parkinson disease. J Neurol Sci.2008;266(1-2):216-28.
Hughes TA, Ross HF, Musa S, Bhattacherjee S, Nathan RN, Mindham RH, et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology. 2000;54(8):1596-602.
Sung VW, Nicholas AP. Nonmotor symptoms in Parkinson's disease: expanding the view of Parkinson's disease beyond a pure motor, pure dopaminergic problem. Neurol Clin. 2013;31(3 Suppl):S1-16.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.